Head of Business Development (M&A)

SSE: 688428) is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing innovative drugs for the treatment of cancers and autoimmune disease, with unmet medical needs worldwide. InnoCare has built up a fully integrated platform in terms of research and development, clinical development, manufacturing and commercialization. To date, the Company has developed a robust product pipeline comprising three approved drugs (orelabrutinib, tafasitamab and zurletrectinib), and more than ten innovative drug candidates in clinical development, and multiple programs in preclinical stages. InnoCare has successfully got listed on both Hong Kong Stock Exchange and the STAR Board of Shanghai Stoch Exchange. Our world-class team exhibits remarkable synergy and efficient execution, with entrepreneurial spirit, which has made outstanding achievements in innovation, commercialization and globalization. If you would like to join us, we will develop innovative drugs for the benefit of patients worldwide. Website link: LinkedIn: InnoCare Pharma. Project Leadership~ Lead discovery projects, formulate medicinal chemistry strategies, engage in compound design and SAR analysis. Team Management~ Manage and motivate a medicinal chemistry team, provide professional guidance to team members, help resolve technical difficulty. PhD degree in Organic Chemistry with over seven years of working experience in the pharmaceutical industry. An expert in medicinal chemistry, ligand- and structure-based drug design.